Cantor Fitzgerald, L. P. Tiziana Life Sciences LTD Transaction History
Cantor Fitzgerald, L. P.
- $656 Million
- Q1 2024
A detailed history of Cantor Fitzgerald, L. P. transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 12,091 shares of TLSA stock, worth $10,398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,091
Previous 12,091
-0.0%
Holding current value
$10,398
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TLSA
# of Institutions
21Shares Held
816KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA216KShares$185,6090.0% of portfolio
-
Hsbc Holdings PLC London, X0164KShares$141,2340.0% of portfolio
-
Morgan Stanley New York, NY126KShares$108,4780.0% of portfolio
-
Ausdal Financial Partners, Inc. Davenport, IA55.7KShares$47,9020.0% of portfolio
-
Ewa, LLC Pittsbugh, PA55.3KShares$47,5580.02% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $88M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...